ArchiMed, European private equity healthcare specialist, announces successful growth of its portfolio company Micromed into Neurodiagnostics – on both sides of the Atlantic.
Archimed expands neurodiagnostic business in Europe and the US
Portfolio Company, Micromed, a European-based neurodiagnostic system manufacturer has moved to direct sales in the United States and its wholly owned subsidiary, US based Moberg ICU Solutions has expanded its reach into Europe.
The strategic integration of these two companies will allow Micromed and Moberg to each leverage the other’s existing geographic footprint. This will allow both companies to increase their reach to Neurologists, Epileptologists, Neurocritical Care Specialists and EEG Technicians across Europe and the United States.
Since the transition to direct sales in the US, Micromed systems have secured a multimillion sale in New England, together with significant expansion projects in all its existing major installations across the United States.
Thanks to the strategic integration, Moberg now has access to Micromed’s European distribution network for its cutting-edge Smart Neuro ICU technologies selling equipment into three major ICU centers in France and Italy.
Rüdiger Hausherr, CEO of Micromed Group, praises the Group’s Senior Management team for its success. The team has been drawn from combining the expertise of Micromed and the integrated companies SIGMA Medizin-Technik and Moberg ICU Solutions – “The combination of our strong International leadership team, superior products and our dedication to customer support globally will continue to ensure our success”.
About ArchiMed – www.archimed-group.eu. ArchiMed is an independent investment firm specialized in the Healthcare industries. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors.
ArchiMed’s international team combines investment, medical, technological and operational experience. It works alongside management teams to accelerate their business growth, through internationalization, product and service range expansion as well as capacity extension, both organically and through acquisitions. Over the last 20 years, ArchiMed’s leadership team directly managed and invested in over 40 small, medium and large-size healthcare companies throughout the world, with a combined value above five billion euros.
ArchiMed’s investment capacity currently exceeds one billion euros and potentially twice this amount when including its strategic investment partners.
About Micromed – Founded in 1982, Micromed is a medical device company delivering solutions in Neurophysiology worldwide. Partnering with hospitals, sleep labs and research centers on a global scale, Micromed manufactures and markets high quality, cost effective and clinically relevant neurodiagnostic solutions for use on adult and pediatric patients. The Micromed product portfolio ranges from Routine, Ambulatory and Video EEG to ECoG, SEEG, PSG, EP and EMG for clinical and research applications in addition to a full line of accessories.
About Moberg ICU Solutions – Moberg ICU Solutions is a medical device manufacturing company specializing in neuromonitoring and information management in acute care. Moberg was founded in 1998 and is located in Ambler. The Company has achieved significant milestones without outside investments. These include development and FDA clearance of its products, obtaining ISO 13485 quality certification, entry into the European market, and annual sales that continue to grow. Independence from investors has resulted in a company that can focus on creating solutions in neurocritical care as they are identified in this emerging discipline.